Articles
| Issue | Title | File | |
| Vol 18, No 4 (2023): Supplement | COVID-19 in patients with acute leukemia: 3 years' experience of pandemic |
![]() (Rus) |
|
| Chudnova T.S., Misyurina E.N., Baryakh E.A., Tolstykh T.N., Shimanovskaya L.T., Gagloeva D.E., Zhelnova E.I., Makeshova A.B., Yatskov K.V., Zotina E.N., Ivanova D.D., Mingalimov M.A., Kochneva O.L., Grishina E.Y., Polyakov Y.Y., Yakimets V.N. | |||
| Vol 18, No 4 (2023): Supplement | Treatment experience of coronavirus infection associated with SARS-CoV-2 in patients with acute myeloid leukemia in the older age group |
![]() (Rus) |
|
| Shimanovskaya L.T., Misyurina E.N., Baryakh E.A., Zhelnova E.I., Yatskov K.V., Chudnova T.S., Makeshova A.B., Mingalimov M.A., Ivanova D.D., Kochneva O.L., Zotina E.N., Tolstykh T.N., Grishina E.Y., Gagloeva D.E., Polyakov Y.Y., Yakimets V.N., Koneva A.I. | |||
| Vol 18, No 4 (2023): Supplement | Prognostic model and risk factors for hospital mortality in patients with diffuse large B-cell lymphoma associated with coronavirus infection: a single-center cohort study |
![]() (Rus) |
|
| Polyakov Y.Y., Baryakh E.A., Misyurina E.N., Zhelnova E.I., Yatskov K.V., Makeshova A.B., Mingalimov M.A., Tolstykh T.N., Chudnova T.S., Ivanova D.D., Koneva A.I., Kochneva O.L., Zotina E.N., Gagloeva D.E., Grishina E.Y., Shimanovskaya L.T., Yakimets V.N. | |||
| Vol 18, No 4 (2023): Supplement | Basic therapeutic approaches to the management of hematology/oncology patients with new coronavirus infection (COVID-19) |
![]() (Rus) |
|
| Misyurina E.N., Baryakh E.A., Frolova N.F., Kotenko O.N., Mutovina Z.Y., Andreev S.S., Tolstykh T.N., Yatskov K.V., Karimova E.A., Makeshova A.B., Rukavitsyn O.A., Misyurin A.V., Polyakov Y.Y., Mingalimov M.A., Chudnova T.S., Gagloeva D.E., Ivanova D.D., Koneva A.I., Kochneva O.L., Zotina E.N., Grishina E.Y., Shimanovskaya L.T., Yakimets V.N., Zhelnova E.I. | |||
| Vol 18, No 4 (2023): Supplement | Treatment features of adult patients with acute myeloid leukemia during the COVID-19 pandemic |
![]() (Rus) |
|
| Gagloeva D.E., Misyurina E.N., Tolstykh T.N., Baryakh E.A., Yatskov K.V., Karimova E.A., Makeshova A.B., Mingalimov M.A., Chudnova T.S., Ivanova D.D., Koneva A.I., Kochneva O.L., Zotina E.N., Grishina E.Y., Shimanovskaya L.T., Yakimets V.N., Zhelnova E.I. | |||
| Vol 18, No 4 (2023): Supplement | Coronavirus infection after blood stem cell transplantation |
![]() (Rus) |
|
| Grishina E.Y., Misyurina E.N., Zhelnova E.I., Baryakh E.A., Yatskov K.V., Makeshova A.B., Karimova E.A., Zotina E.N., Gagloeva D.E., Yakimets V.N., Mingalimov M.A., Tolstykh T.N., Polyakov Y.Y., Chudnova T.S., Kochneva O.L., Shimanovskaya L.T. | |||
| Vol 18, No 4 (2023): Supplement | Clinical features and treatment strategy for patients with multiple myeloma during the COVID-19 pandemic |
![]() (Rus) |
|
| Yakimets V.N., Misyurina E.N., Zhelnova E.I., Baryakh E.A., Yatskov K.V., Makeshova A.B., Karimova E.A., Zotina E.N., Grishina E.Y., Gagloeva D.E., Mingalimov M.A., Tolstykh T.N., Chudnova T.S., Kochneva O.L., Shimanovskaya L.T., Polyakov Y.Y. | |||
| Vol 18, No 4 (2023): Supplement | Chronic lymphocytic leukemia in combination with COVID-19: clinical features and unfavorable prognosis factors |
![]() (Rus) |
|
| Kochneva O.L., Baryakh E.A., Misyurina E.N., Zhelnova E.I., Yatskov K.V., Chudnova T.S., Polyakov Y.Y., Makeshova A.B., Mingalimov M.A., Ivanova D.D., Shimanovskaya L.T., Zotina E.N., Tolstykh T.N., Grishina E.Y., Gagloeva D.E., Yakimets V.N., Koneva A.I., Karimova E.A. | |||
| Vol 14, No 1 (2019) | Information for authors |
![]() (Rus) |
|
| Editorial a. | |||
| 1 - 9 of 9 Items | |||

